Published in Cell Mol Life Sci on July 08, 2012
Autophagy and neurodegeneration. J Clin Invest (2015) 1.24
Leucine-rich repeat kinase 2 (LRRK2)-deficient rats exhibit renal tubule injury and perturbations in metabolic and immunological homeostasis. PLoS One (2013) 0.98
Inhibition of LRRK2 kinase activity stimulates macroautophagy. Biochim Biophys Acta (2013) 0.98
Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy. Hum Mol Genet (2014) 0.98
Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications. Neurotherapeutics (2014) 0.94
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J Neurochem (2016) 0.91
LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis. Exp Neurol (2014) 0.88
LRRK2: cause, risk, and mechanism. J Parkinsons Dis (2013) 0.88
Pathogenic Parkinson's disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation. Biochem Biophys Res Commun (2013) 0.87
Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagy. Biochim Biophys Acta (2014) 0.87
Cellular processes associated with LRRK2 function and dysfunction. FEBS J (2015) 0.86
The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease. Neuroscience (2014) 0.85
Mitochondria: A Therapeutic Target for Parkinson's Disease? Int J Mol Sci (2015) 0.85
The role of the LRRK2 gene in Parkinsonism. Mol Neurodegener (2014) 0.85
Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China. Genes Immun (2014) 0.82
Mitochondrial impairment increases FL-PINK1 levels by calcium-dependent gene expression. Neurobiol Dis (2013) 0.82
Autophagy plays a critical role in ChLym-1-induced cytotoxicity of non-hodgkin's lymphoma cells. PLoS One (2013) 0.82
The associations between Parkinson's disease and cancer: the plot thickens. Transl Neurodegener (2015) 0.81
A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's Disease. Parkinsons Dis (2012) 0.80
An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease. Neurobiol Dis (2015) 0.80
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease. Curr Neuropharmacol (2016) 0.78
A mycobacterial phosphoribosyltransferase promotes bacillary survival by inhibiting oxidative stress and autophagy pathways in macrophages and zebrafish. J Biol Chem (2015) 0.78
mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1. Sci Rep (2016) 0.78
Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson's Disease. Parkinsons Dis (2016) 0.78
ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression. Protein Cell (2013) 0.77
ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease. Biochim Biophys Acta (2013) 0.76
LRRK2 at the interface of autophagosomes, endosomes and lysosomes. Mol Neurodegener (2016) 0.76
Dysregulation of autophagy and mitochondrial function in Parkinson's disease. Transl Neurodegener (2016) 0.75
The LRRK2-macroautophagy axis and its relevance to Parkinson's disease. Biochem Soc Trans (2017) 0.75
Parkinson's disease: leucine-rich repeat kinase 2 and autophagy, intimate enemies. Parkinsons Dis (2012) 0.75
Emerging preclinical pharmacological targets for Parkinson's disease. Oncotarget (2016) 0.75
Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds. Int J Mol Sci (2017) 0.75
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron (2004) 13.99
An immunosurveillance mechanism controls cancer cell ploidy. Science (2012) 4.35
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain (2005) 3.61
Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells (2007) 2.71
Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet (2002) 2.65
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood (2004) 2.61
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol Ther (2006) 2.41
Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells (2006) 2.37
Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J (2005) 2.16
Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Mol Cell (2012) 2.14
Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One (2009) 1.98
[Fabry disease from the neurologist's point of view: is it a rare cause of strokes?]. Rev Neurol (2015) 1.97
Autophagy is required for the activation of NFκB. Cell Cycle (2012) 1.89
Inhibition of paraquat-induced autophagy accelerates the apoptotic cell death in neuroblastoma SH-SY5Y cells. Toxicol Sci (2007) 1.87
Autophagic removal of micronuclei. Cell Cycle (2012) 1.85
Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur J Immunol (2007) 1.76
The architecture of the left lateral atrial wall: a particular anatomic region with implications for ablation of atrial fibrillation. Eur Heart J (2008) 1.60
Oncogenicity of the developmental transcription factor Sox9. Cancer Res (2012) 1.55
Morphological evidence of muscular connections between contiguous pulmonary venous orifices: relevance of the interpulmonary isthmus for catheter ablation in atrial fibrillation. Heart Rhythm (2009) 1.46
Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Rep (2012) 1.45
Regulation of autophagy by stress-responsive transcription factors. Semin Cancer Biol (2013) 1.44
[Annexin V levels in survivors of early myocardial infarction]. Rev Esp Cardiol (2002) 1.44
Capillary supply to the sinus node in subjects with long-term atrial fibrillation. Ann Thorac Surg (2010) 1.42
Does pacemaker implantation provide long-term benefits in severe obstructive hypertrophic cardiomyopathy? Rev Esp Cardiol (2009) 1.41
A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro Oncol (2014) 1.40
How close are the phrenic nerves to cardiac structures? Implications for cardiac interventionalists. J Cardiovasc Electrophysiol (2005) 1.40
Novel valosin containing protein mutation in a Swiss family with hereditary inclusion body myopathy and dementia. Neuromuscul Disord (2012) 1.40
[Plasma concentration of big endothelin-1 and its relation with plasma NT-proBNP and ventricular function in heart failure patients]. Rev Esp Cardiol (2005) 1.38
Anatomic relations between the esophagus and left atrium and relevance for ablation of atrial fibrillation. Circulation (2005) 1.38
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. J Neurosci (2004) 1.35
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. Eur J Neurosci (2006) 1.32
Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins. Cell Cycle (2012) 1.27
Inhibition of autophagy by TAB2 and TAB3. EMBO J (2011) 1.15
Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels. Neurobiol Dis (2008) 1.13
Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget's disease of bone and frontotemporal dementia. Neuromuscul Disord (2009) 1.12
Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology (2010) 1.12
Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia. Neurobiol Aging (2013) 1.12
Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy. Thromb Res (2010) 1.08
Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor. Cancer Res (2004) 1.08
Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model. Neuroimage (2003) 1.07
Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings. Biol Psychiatry (2007) 1.01
Nitric oxide in paraquat-mediated toxicity: A review. J Biochem Mol Toxicol (2010) 1.00
Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide. Hum Mutat (2012) 0.99
Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2/Trx axis. Free Radic Biol Med (2010) 0.98
Current mutation discovery approaches in Retinitis Pigmentosa. Vision Res (2012) 0.98
Identification of a novel THAP1 mutation at R29 amino-acid residue in sporadic patients with early-onset dystonia. Mov Disord (2009) 0.98
Silencing DJ-1 reveals its contribution in paraquat-induced autophagy. J Neurochem (2009) 0.97
Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease. J Neurosurg (2003) 0.95
Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2. Mov Disord (2009) 0.95
Protection against MPP+ neurotoxicity in cerebellar granule cells by antioxidants. Cell Biol Int (2004) 0.94
Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques. Mov Disord (2006) 0.93
Fipronil is a powerful uncoupler of oxidative phosphorylation that triggers apoptosis in human neuronal cell line SHSY5Y. Neurotoxicology (2011) 0.93
Gene expression profiling in limb-girdle muscular dystrophy 2A. PLoS One (2008) 0.93
Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy. J Card Fail (2010) 0.93
Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy. Eur J Intern Med (2011) 0.92
Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations. Mov Disord (2011) 0.92
Anatomic evaluation of the left phrenic nerve relevant to epicardial and endocardial catheter ablation: implications for phrenic nerve injury. Heart Rhythm (2009) 0.92
Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail (2005) 0.91
Gonadotropin-releasing hormone-induced activation of diacylglycerol kinase-zeta and its association with active c-src. J Biol Chem (2004) 0.90
Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism. Neurobiol Dis (2008) 0.90
Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. Alzheimer Dis Assoc Disord (2013) 0.90
Paraquat-induced apoptotic cell death in cerebellar granule cells. Brain Res (2004) 0.90
Genetic high throughput screening in Retinitis Pigmentosa based on high resolution melting (HRM) analysis. Exp Eye Res (2013) 0.89
Genetic variability related to serum uric acid concentration and risk of Parkinson's disease. Mov Disord (2013) 0.88
Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis. Biomark Med (2014) 0.87
Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain). Mov Disord (2010) 0.87
Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia. BMC Neurol (2010) 0.87
MPP+: mechanism for its toxicity in cerebellar granule cells. Mol Neurobiol (2004) 0.86
Paraquat exposure induces nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the activation of the nitric oxide-GAPDH-Siah cell death cascade. Toxicol Sci (2010) 0.86
Coexistence of protease sensitive and resistant prion protein in 129VV homozygous sporadic Creutzfeldt-Jakob disease: a case report. J Med Case Rep (2012) 0.86
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1? Stroke (2003) 0.86
Modeling neural differentiation on micropatterned substrates coated with neural matrix components. Front Cell Neurosci (2012) 0.86
Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study. Heart (2007) 0.86
ASK1 overexpression accelerates paraquat-induced autophagy via endoplasmic reticulum stress. Toxicol Sci (2010) 0.85
Trimetazidine induces parkinsonism, gait disorders and tremor. Therapie (2005) 0.84
[Structural features of the sinus of valsalva and the proximal portion of the coronary arteries: their relevance to retrograde aortocoronary dissection]. Rev Esp Cardiol (2006) 0.83
Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail (2008) 0.83
Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy. Stem Cells Int (2012) 0.83
Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients. Eur J Heart Fail (2006) 0.83
Protective effect of the glial cell line-derived neurotrophic factor (GDNF) on human mesencephalic neuron-derived cells against neurotoxicity induced by paraquat. Environ Toxicol Pharmacol (2010) 0.83
Relationship between autophagy and apoptotic cell death in human neuroblastoma cells treated with paraquat: could autophagy be a "brake" in paraquat-induced apoptotic death? Autophagy (2007) 0.82